Literature DB >> 1761442

Management of biliary tract infections: potential role of the quinolones.

J F Westphal1, J F Blicklé, J M Brogard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1761442     DOI： 10.1093/jac/28.4.486

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections.

Authors:  Gabrio Bassotti; Fabio Chistolini; Francis Sietchiping-Nzepa; Giuseppe De-Roberto; Antonio Morelli
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

Review 2.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Fluoroquinolones and surgical prophylaxis.

Authors:  P Dellamonica; E Bernard
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 4.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

5.  Resistant pathogens in biliary obstruction: importance of cultures to guide antibiotic therapy.

Authors:  Michael J Englesbe; Lillian G Dawes
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 6.  Clinical pharmacokinetics of newer antibacterial agents in liver disease.

Authors:  J F Westphal; J M Brogard
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.